Date: 10.11.2020
From: Pat Hagan
|
Subject: upadacitinib
Hi. I'm a health journalist writing about upadacitinib for rheumatoid arthritis and looking to interview a patient who has been on it and done really well. 15 minute phone chat today or tomorrow. It's for the Mail on Sunday health section this week.
|